Literature DB >> 12597911

Simultaneous inhibition of GSK3alpha and GSK3beta using hairpin siRNA expression vectors.

Jenn-Yah Yu1, Jennifer Taylor, Stacy L DeRuiter, Anne B Vojtek, David L Turner.   

Abstract

Short interfering RNAs (siRNAs) can mediate sequence-specific inhibition of gene expression in mammalian cells. We and others have recently developed expression vector-based systems for synthesizing siRNAs or hairpin siRNAs in mammalian cells. Expression vector-based RNA interference (RNAi) effectively suppresses expression of target genes and is likely to be a powerful tool for analysis of gene function. Here we compare inhibition by vectors expressing hairpin siRNA designs either with different loop sequences connecting the two siRNA strands, or with duplex regions of different lengths. Our results suggest that lengthening the 19-nucleotide duplex region of a relatively ineffective hairpin siRNA can increase inhibition, but increasing the length of an effective 19-nt hairpin siRNA does not increase inhibition. We also demonstrate that hairpin siRNA vectors can be used to inhibit two target genes simultaneously. We have targeted glycogen synthase kinase-3alpha (GSK-3alpha) and GSK-3beta, two related kinases involved in the regulation of a variety of cellular processes and also implicated in the pathogenesis of several human diseases. Inhibition of either GSK-3alpha or GSK-3beta by transfection of hairpin siRNA vectors leads to elevated expression of the GSK-3 target beta-catenin, whereas inhibition of both kinases further increases beta-catenin expression. Our results suggest that vector-based siRNA inhibition may be useful for dissecting the functional roles of GSK-3alpha and GSK-3beta in somatic cells. The ability to inhibit two or more genes simultaneously with hairpin siRNA expression vectors should facilitate studies of gene function in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12597911     DOI: 10.1016/s1525-0016(02)00037-0

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  43 in total

1.  Activation of Glycogen Synthase Kinase-3 Mediates the Olfactory Deficit-Induced Hippocampal Impairments.

Authors:  Juan Hu; He-Zhou Huang; Xiang Wang; Ao-Ji Xie; Xiong Wang; Dan Liu; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2014-11-05       Impact factor: 5.590

2.  A 10 residue motif at the C-terminus of the RNA pol II CTD is required for transcription, splicing and 3' end processing.

Authors:  Nova Fong; Gregory Bird; Marc Vigneron; David L Bentley
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

3.  Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interference.

Authors:  Sebastian Schuck; Aki Manninen; Masanori Honsho; Joachim Füllekrug; Kai Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

4.  Effect of vector-expressed shRNAs on hTERT expression.

Authors:  Ying Guo; Jun Liu; Ying-Hui Li; Tian-Bao Song; Jing Wu; Cai-Xia Zheng; Cai-Fang Xue
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

5.  Suppression of prion protein in livestock by RNA interference.

Authors:  Michael C Golding; Charles R Long; Michelle A Carmell; Gregory J Hannon; Mark E Westhusin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

6.  Silencing of hepatitis A virus infection by small interfering RNAs.

Authors:  Yuri Kusov; Tatsuo Kanda; Ann Palmenberg; Jean-Yves Sgro; Verena Gauss-Müller
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation.

Authors:  Jenn-Yah Yu; Kwan-Ho Chung; Monika Deo; Robert C Thompson; David L Turner
Journal:  Exp Cell Res       Date:  2008-06-07       Impact factor: 3.905

Review 8.  RNA interference and nonviral targeted gene therapy of experimental brain cancer.

Authors:  Ruben J Boado
Journal:  NeuroRx       Date:  2005-01

Review 9.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

10.  Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.

Authors:  Venugopalan D Nair; C Warren Olanow
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.